Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Markus, Wiesneth"'
Autor:
Jochen Greiner, Susanne Hofmann, Michael Schmitt, Marlies Götz, Markus Wiesneth, Hubert Schrezenmeier, Donald Bunjes, Hartmut Döhner, Lars Bullinger
Publikováno v:
Haematologica, Vol 102, Iss 12 (2017)
Externí odkaz:
https://doaj.org/article/3861ae320a0e482592502b0aaad20fc9
Autor:
Wolfgang A. Bethge, Matthias Eyrich, Stephan Mielke, Roland Meisel, Dietger Niederwieser, Paul G. Schlegel, Ansgar Schulz, Johann Greil, Donald Bunjes, Arne Brecht, Jurgen Kuball, Michael Schumm, Vladan Vucinic, Markus Wiesneth, Halvard Bonig, Kasper Westinga, Stefanie Biedermann, Silke Holtkamp, Sandra Karitzky, Michaela Malchow, Christiane Siewert, Rupert Handgretinger, Peter Lang
Publikováno v:
Bone Marrow Transplantation
Hematopoietic stem cell transplantation (HSCT) from haploidentical donors is a viable option for patients lacking HLA-matched donors. Here we report the results of a prospective multicenter phase I/II trial of transplantation of TCRαβ and CD19-depl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d15987cc42b231ca9a41cc88cf8bd20
https://pubmed.ncbi.nlm.nih.gov/34952929
https://pubmed.ncbi.nlm.nih.gov/34952929
Autor:
Markus Wiesneth
Publikováno v:
Transfusionsmedizin - Immunhämatologie, Hämotherapie, Immungenetik, Zelltherapie. 7:173-180
ZusammenfassungAufgrund der Änderung des Arzneimittelgesetzes (AMG) vom 21. November 2016 sind hämatopoetische Stammzellzubereitungen (HSZZ) aus Knochenmark, peripherem Blut oder Nabelschnurblut ab dem 29. April 2017 vor dem Inverkehrbringen zur An
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e3b0b950a413cf396260874af8f330a
https://doi.org/10.1055/s-0043-116012
https://doi.org/10.1055/s-0043-116012
Autor:
Hubert Schrezenmeier, Paul Schnitzler, Donald Bunjes, Anthony D. Ho, Peter Dreger, Angela Hückelhoven, Hartmut Döhner, Markus Wiesneth, Marlies Götz, Peter Schauwecker, Lei Wang, Birgit Michels, Susanne Hofmann, Michael Schmitt, Thomas Mertens, Anita Schmitt, Volker Eckstein, Patrick Wuchter, Jochen Greiner, Birgit Maccari, Zeguang Wu, Jürgen Kuball
Publikováno v:
Theranostics
Theranostics, 7(6), 1705. Ivyspring International Publisher
Theranostics, 7(6), 1705. Ivyspring International Publisher
Rationale: Patients receiving an allogeneic stem cell graft from cytomegalovirus (CMV) seronegative donors are particularly prone to CMV reactivation with a high risk of disease and mortality. Therefore we developed and manufactured a novel vaccine a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::669048c91531213d65c41e92b7239f09
http://europepmc.org/articles/PMC5436522
http://europepmc.org/articles/PMC5436522
Autor:
Susanne Hofmann, Vanessa Schneider, Marlies Götz, Jochen Greiner, Markus Wiesneth, Hubert Schrezenmeier
Publikováno v:
Blood. 136:15-15
Nucelophosmin1 (NPM1) is one of the most commonly mutated genes in AML, represents a distinct entity according to the WHO and is commonly associated with a favorable prognosis. We described specific immune responses against immunogenic epitopes deriv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a7ee7fca76814335a5642eb5438c5ab
https://doi.org/10.1182/blood-2020-134876
https://doi.org/10.1182/blood-2020-134876
Autor:
Susanne, Hofmann, Michael, Schmitt, Marlies, Götz, Hartmut, Döhner, Markus, Wiesneth, Donald, Bunjes, Jochen, Greiner
Publikováno v:
International journal of cancer. 144(5)
T cell responses against malignant cells play a major role in maintaining remission and prolonging overall survival in patients after allogeneic stem cell transplantation and donor lymphocyte infusion (DLI) due to graft-versus-leukemia effect. For be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5da6346a341adf88d9b49e11c54c346f
https://pubmed.ncbi.nlm.nih.gov/30006990
https://pubmed.ncbi.nlm.nih.gov/30006990
Autor:
Markus Wiesneth, Hubert Schrezenmeier, Vanessa Schneider, Jochen Greiner, Konstanze Döhner, Hartmut Döhner, Liling Zhang, Marlies Götz, Ursula Botzenhardt, Markus Rojewski, S Hofmann, Lars Bullinger, T F E Barth
Publikováno v:
Leukemia. 28:1759-1762
Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e451b55cafd3ebd3bcb1c2c6db1f8b9
https://doi.org/10.1038/leu.2014.116
https://doi.org/10.1038/leu.2014.116
Autor:
Markus Wiesneth, Jochen Wöhrle, Wolfgang Rottbauer, Peter Schauwecker, Hubert Schrezenmeier, Sinisa Markovic, Fabian von Scheidt, Vinzenz Hombach, Peter Bernhardt
Publikováno v:
Clinical Research in Cardiology. 102:765-770
In patients with acute myocardial infarction (AMI), the number of transplanted autologous bone-marrow cells (BMC) has been linked to improvement in left ventricular ejection fraction (LVEF). Complete obstruction of myocardial microvasculature is indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d935c248f5f2ae44aaab222f4abf6c3f
https://doi.org/10.1007/s00392-013-0595-9
https://doi.org/10.1007/s00392-013-0595-9
Autor:
Gerrit Jan Schuurhuis, Mike Halpenny, D. Gounder, M. Grommé, Halvard Bonig, Minoko Takanashi, Elaine Forrest, I. Van Riet, SJ Ragg, Eric Braakman, Markus Wiesneth, Mindy Goldman, Nina Worel, Rita Fontão-Wendel, George Galea, P. Accorsi, Jess Oh, Rachel Pawson, Konrad Rosskopf, Peter Schauwecker, Hubert Schrezenmeier, T. Bonfini, Anthony Giulivi, Andreas Humpe, Erhard Seifried, Jo Anna Reems, Ute Buwitt-Beckmann, Angela Brand, A. Wong, Reinhard Henschler, Jon Smythe, Matti Korhonen, R. Dooccey, Frank Preijers, Henk W. Reesink, Simon Panzer, Anne Arvola, Brenda Letcher, Locksley Mcgann, Arlete Lazar, J. M. van Beckhoven, Silvano Wendel
Publikováno v:
Vox Sanguinis. 101:255-275
The final quality control of cryopreserved progenitor cells is a successful and persistent three lineage engraftment after transplantation. Of course, the stem cell providing institution is obliged to have a program for controlling and monitoring the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c83ace4be3802f2733c0925804716c9
https://doi.org/10.1111/j.1423-0410.2011.01471.x
https://doi.org/10.1111/j.1423-0410.2011.01471.x
Autor:
Goetz Ulrich Grigoleit, Lothar Germeroth, Jochen Greiner, Thomas Mertens, Marcus Odendahl, Donald Bunjes, Anita Schmitt, Stephanie von Harsdorf, Hartmut Döhner, Simone Ringhoffer, Markus Wiesneth, Michael Schmitt, Hermann Einsele, Erhard Seifried, Dirk H. Busch, Mark Ringhoffer, Detlef Michel, Torsten Tonn, Markus Rojewski, Martin Marx
Publikováno v:
Transfusion. 51:591-599
BACKGROUND: Cytomegalovirus (CMV) disease constitutes a serious complication after allogeneic stem cell transplantation. For the clearance of CMV, CD8+ T cells are pivotal. STUDY DESIGN AND METHODS: Here, the novel streptamer technology was used at g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77b8cb44ffa2dfa7a902fea4851c42bf
https://doi.org/10.1111/j.1537-2995.2010.02940.x
https://doi.org/10.1111/j.1537-2995.2010.02940.x